A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

NCT05714072 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis Due to and Following Polycythemia Vera

Interventions

DRUG: Ruxolitinib
DRUG: Abemaciclib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]